Think Research
Knowledge-based tools and leading clinical content for clinicians at the point of care.
Enterprise value
$53m
Share price
CAD0.32 THNK.V
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A Valuation: $25.4m 0.4x EV/Revenue 5.2x EV/EBITDA | Acquisition | |
| Total Funding | 000k | ||
Fidelity Investments(exited)
NAventures(exited)
LVL1 Group(exited)
Lumira Ventures(exited)
Beedie Capital(exited)
Scotiabank(exited)
Canaccord Genuity(exited)
| CAD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 146 % | 64 % | 7 % | 9 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (35 %) | (29 %) | (7 %) | 2 % | 7 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (52 %) | (61 %) | (33 %) | (18 %) | (16 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 23 % | 14 % | 9 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Think Research
Edit
ACQUISITION by Think Research Nov 2021
ACQUISITION by HEALWELL Jun 2024
ACQUISITION by Think Research Jan 2021
ACQUISITION by Think Research Feb 2021